New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 22, 2014
07:01 EDTNPSPNPS Pharmaceuticals coverage resumed with a Buy at Janney Capital
Target $37.
News For NPSP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 24, 2014
10:29 EDTNPSPOptions with decreasing implied volatility
Subscribe for More Information
10:03 EDTNPSPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:18 EDTNPSPOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Microsoft (MSFT), up 4.3%... KLA-Tencor (KLAC), up 8.8%... Rubicon Project (RUBI), up 17.8%... Gigamon (GIMO), up 16%. ALSO HIGHER: Procter & Gamble (PG), up 2.7% after earning report, announcing plans to exit Duracell business by creating a stand-alone Duracell company... Vitae Pharmaceuticals (VTAE), up 40% following its report of top-line results from two Phase 1 clinical trials... Digital River (DRIV), up 47% after agreeing to be acquired by investor group for $26.00 per share. LOWER: Amazon (AMZN), down 9.3%, downgraded at Cowen and Janney Capital following the company's Q3 report... DryShips (DRYS), down 26% after filing an automatic common stock shelf... NPS Pharmaceuticals (NPSP), down 4.4% following PDUFA date for Natpara extended three months to January 24... Abercrombie & Fitch (ANF), down 4% after downgraded at Goldman and BMO Capital. DOWN AFTER EARNINGS: Pandora (P), down 7%... Synaptics (SYNA), down 9.9%... Flowserve (FLS), down 5%... New Oriental Education (EDU), down 4%.
09:09 EDTNPSPNPS Pharmaceuticals worst case scenario unlikely, says BofA/Merrill
Subscribe for More Information
08:41 EDTNPSPNPS Pharmaceuticals downgraded to Neutral from Buy at Goldman
Subscribe for More Information
05:54 EDTNPSPStocks with implied volatility movement; NPSP HLF
Subscribe for More Information
October 23, 2014
18:52 EDTNPSPOn The Fly: After Hours Movers
UP AFTER EARNINGS: Rubicon Project (RUBI), up 19.2%... KLA-Tencor (KLAC), up 15.8%... Gigamon (GIMO), up 13.5%... Maxwell (MXWL), up 11.3%... Qlik Technologies (QLIK), up 9.8%... NetSuite (N), up 5.5%... Microsoft (MSFT), up 3.3%... Juniper Networks (JNPR), reverses in after-hours trading and is up 1.4% after reporting third quarter results and announcing a $1.1B increase to the company's share repurchase authorization. ALSO HIGHER: Vitae Pharmaceuticals (VTAE), up 38.6% following positive top-line results from two Phase 1 clinical trials of BI1181181/VTP-37948... Pfizer (PFE), up 1.8% after announcing a new $11B share repurchase program. DOWN AFTER EARNINGS: Amazon.com (AMZN), down 10.7%... Synaptics(SYNA), down 12.7%... Pandora (P), down 6.8%... Lattice Semiconductor (LSCC), down 5.6%... Maxim Integrated (MXIM), down 5.8%. ALSO LOWER: DryShips (DRYS), down 16.5% after filing an automatic common stock shelf... NPS Pharmaceuticals (NPSP), down 7.9% following PDUFA date for Natpara extended three months to January 24... GoPro (GPRO), down 2.8% after being initiated with an Underperform at Oppenheimer.
16:47 EDTNPSPNPS Pharmaceuticals PDUFA date for Natpara extended three months to January 24
NPS Pharmaceuticals reported that the FDA has extended the company’s Prescription Drug User Fee Act, or PDUFA, action date for its Natpara Biologics License Application by three months from October 24 to January 24, 2015. The FDA extended the action date to provide time for a full review of a major amendment; such extensions are provided for by regulation. In addition, the FDA requested that NPS Pharma submit a Risk Evaluation and Mitigation Strategy, or REMS, for Natpara and the company is working to finalize the REMS in advance of the revised PDUFA action date. To date, the FDA has not requested that additional clinical studies be completed prior to the approval of Natpara; however, the company expects a post-approval study commitment. Francois Nader CEO of NPS Pharma said, “We continue to advance our commercial readiness activities and are planning for the launch of Natpara in 2Q15.”
October 21, 2014
09:48 EDTNPSPShire could target BioMarin, TheStreet's Feuerstein says
Subscribe for More Information
October 20, 2014
09:22 EDTNPSPOn The Fly: Pre-market Movers
Subscribe for More Information
06:56 EDTNPSPShire reopens acquistion talks with NPS Pharmaceuticals, Cubist, Telegraph says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use